Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
Switzerland
/
Pharmaceuticals & Biotech
Create a narrative
PolyPeptide Group Community
SWX:PPGN Community
1
Narratives
written by author
0
Comments
on narratives written by author
3
Fair Values set
on narratives written by author
Create a narrative
PolyPeptide Group
Popular
Undervalued
Overvalued
Community Investing Ideas
There are no community narratives available.
Your Valuation for
PPGN
PPGN
PolyPeptide Group
Your Fair Value
CHF
Current Price
CHF 18.12
56.8% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-51m
666m
2015
2018
2021
2024
2025
2027
2030
Revenue €665.8m
Earnings €80.7m
Advanced
Set Fair Value